Espeland, K.; Christensen, E.; Aandahl, A.; Ulvær, A.; Warloe, T.; Kleinauskas, A.; Darvekar, S.; Juzenas, P.; Vasovic, V.; Peng, Q.;
et al. Extracorporeal Photopheresis with 5-Aminolevulinic Acid in Crohn’s Disease—A First-in-Human Phase I/II Study. J. Clin. Med. 2024, 13, 6198.
https://doi.org/10.3390/jcm13206198
AMA Style
Espeland K, Christensen E, Aandahl A, Ulvær A, Warloe T, Kleinauskas A, Darvekar S, Juzenas P, Vasovic V, Peng Q,
et al. Extracorporeal Photopheresis with 5-Aminolevulinic Acid in Crohn’s Disease—A First-in-Human Phase I/II Study. Journal of Clinical Medicine. 2024; 13(20):6198.
https://doi.org/10.3390/jcm13206198
Chicago/Turabian Style
Espeland, Kristian, Eidi Christensen, Astrid Aandahl, Andreas Ulvær, Trond Warloe, Andrius Kleinauskas, Sagar Darvekar, Petras Juzenas, Vlada Vasovic, Qian Peng,
and et al. 2024. "Extracorporeal Photopheresis with 5-Aminolevulinic Acid in Crohn’s Disease—A First-in-Human Phase I/II Study" Journal of Clinical Medicine 13, no. 20: 6198.
https://doi.org/10.3390/jcm13206198
APA Style
Espeland, K., Christensen, E., Aandahl, A., Ulvær, A., Warloe, T., Kleinauskas, A., Darvekar, S., Juzenas, P., Vasovic, V., Peng, Q., & Jahnsen, J.
(2024). Extracorporeal Photopheresis with 5-Aminolevulinic Acid in Crohn’s Disease—A First-in-Human Phase I/II Study. Journal of Clinical Medicine, 13(20), 6198.
https://doi.org/10.3390/jcm13206198
